HCPCS Code Q2042
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Short Description | Tisagenlecleucel car-pos t |
|---|---|
| Year | 2026 |
| Coverage Code | C = Carrier judgment |
| Action Code | N = No maintenance for this code |
| Action Effective Date | January 01, 2019 |
| Code Added Date | January 01, 2019 |
| Pricing Indicator | 51 = Drugs |
| Type of Service | 1 = Medical care |